Melanoma Cell Resistance to Vemurafenib Modifies Inter-Cellular Communication Signals

The therapeutic success of BRAF inhibitors (BRAFi) and MEK inhibitors (MEKi) in BRAF-mutant melanoma is limited by the emergence of drug resistance, and several lines of evidence suggest that changes in the tumor microenvironment can play a pivotal role in acquired resistance. The present study focu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biomedicines
Egile Nagusiak: Tabolacci, Claudio, Cordella, Martina, Mariotti, Sabrina, Rossi, Stefania, Senatore, Cinzia, Lintas, Carla, Levati, Lauretta, D’Arcangelo, Daniela, Facchiano, Antonio, D’Atri, Stefania, Nisini, Roberto, Facchiano, Francesco
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7830125/
https://ncbi.nlm.nih.gov/pubmed/33467521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9010079
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak